Vistin Pharma
A leading global producer of Metformin Hydrochloride for the global healthcare market.
VISTN | OL
Overview
Corporate Details
- ISIN(s):
- NO0010734122
- LEI:
- 5967007LIEEXZXFQY092
- Country:
- Norway
- Address:
- Postboks 6735 Etterstad, 0609 Oslo
- Website:
- https://www.vistin.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vistin Pharma is a specialized pharmaceutical company and a leading global producer of Metformin Hydrochloride, the standard first-line treatment for Type 2 diabetes. The company operates as a pure-play metformin supplier, producing both Active Pharmaceutical Ingredients (API) and Direct Compressible (DC) grades for the global healthcare market. As a dedicated European manufacturer, Vistin Pharma is positioned to supply a significant portion of the world's demand for this essential medicine, with a focus on high-quality and sustainable production.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-31 07:40 |
Investor Presentation
Vistin Pharma ASA: Third quarter and YTD 2025 financial results - Attachment: V…
|
English | 1.7 MB | ||
| 2025-10-31 07:40 |
Quarterly Report
Vistin Pharma ASA: Third quarter and YTD 2025 financial results - Attachment: V…
|
English | 1.5 MB | ||
| 2025-10-31 07:40 |
Earnings Release
Vistin Pharma ASA: Third quarter and YTD 2025 financial results
|
English | 2.2 KB | ||
| 2025-10-24 10:00 |
Report Publication Announcement
Vistin Pharma ASA: Invitation to Q3 2025 conference call
|
English | 2.6 KB | ||
| 2025-08-15 08:00 |
Interim Report
Vistin Pharma ASA: Second quarter and YTD 2025 financial results - Attachment: …
|
English | 1.6 MB | ||
| 2025-08-15 08:00 |
Investor Presentation
Vistin Pharma ASA: Second quarter and YTD 2025 financial results - Attachment: …
|
English | 1.9 MB | ||
| 2025-08-15 08:00 |
Earnings Release
Vistin Pharma ASA: Second quarter and YTD 2025 financial results
|
English | 2.1 KB | ||
| 2025-08-08 10:00 |
Regulatory News Service
Vistin Pharma ASA: Invitation to Q2 2025 conference call
|
English | 1.6 KB | ||
| 2025-06-04 08:00 |
Notice of Dividend Amount
Ex dividend NOK 1.25 today
|
English | 330 bytes | ||
| 2025-05-23 09:22 |
Report Publication Announcement
Financial calendar
|
English | 464 bytes | ||
| 2025-05-23 09:22 |
Report Publication Announcement
Finansiell kalender
|
Norwegian | 448 bytes | ||
| 2025-05-22 12:59 |
Post-Annual General Meeting Information
Vistin Pharma ASA: Minutes from the annual general meeting 2025
|
English | 897.7 KB | ||
| 2025-05-22 12:59 |
Post-Annual General Meeting Information
Vistin Pharma ASA: Minutes from the annual general meeting 2025
|
English | 736 bytes | ||
| 2025-05-22 09:56 |
Proxy Solicitation & Information Statement
Disclosure of voting rights at AGM in Vistin Pharma ASA
|
English | 963 bytes | ||
| 2025-05-07 13:30 |
Board/Management Information
Vistin Pharma ASA (VISTN): Update from the Election Committee
|
English | 1.3 KB |
Automate Your Workflow. Get a real-time feed of all Vistin Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Vistin Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Vistin Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
